Physician

Galyna Pushchinska, MD

According to 2025 Medicare claims, Galyna Pushchinska, MD (NPI: 1710147558) practices epileptologists in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Suffolk, NY. This provider's primary affiliated billing organization is NEUROLOGY ASSOCIATES OF STONY BROOK, UNIVERSITY FACULTY PRACTICE CORPO (NPI: 1699720888; TIN: 112587430) and primary practice location at 11790-0989. Pushchinska is affiliated with the Stony Brook ACO, LLC. (ACO ID: A4830), participating under the MSSP model.

Pushchinska's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 436 traditional Medicare patients, billed 2,050 HCPCS/CPT codes, and received $99,780 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 1,980 prescription claims across 249 beneficiaries totaling $748,005 in drug costs, led by Briviact (Brivaracetam). DME data shows 11 claims. Open Payments data shows 5 records totaling $456. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $69,296 to $99,780. Similarly, Part D prescription costs have moved sharply higher in recent years, from $161,091 to $748,005. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	340	632	$69,296
2016	299	788	$62,246
2017	334	658	$59,883
2018	349	594	$73,739
2019	410	645	$85,969
2020	305	503	$61,624
2021	350	562	$80,102
2022	360	547	$80,348
2023	418	1,639	$102,247
2024	436	2,050	$99,780

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	97	604	$161,091
2016	114	652	$157,111
2017	115	695	$234,842
2018	129	798	$273,036
2019	148	903	$325,877
2020	147	1,067	$307,041
2021	172	1,169	$371,215
2022	172	1,319	$422,621
2023	185	1,404	$488,859
2024	249	1,980	$748,005

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	11	$724

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95720	Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional	108	145	$188
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	105	121	$141
95718	Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional	40	41	$122
95816	Measurement of brain wave activity (eeg), awake and drowsy	51	51	$115
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	125	152	$109

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Briviact	Brivaracetam	43	1,515	$85,544
Keppra	Levetiracetam	13	1,110	$76,207
Epidiolex	Cannabidiol (Cbd)	18	510	$72,778
Aptiom	Eslicarbazepine Acetate	12	720	$56,501
Lamictal Xr	Lamotrigine	12	960	$34,482

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0745	Neuromuscular stimulator, electronic shock unit	Y	N/R	11	$724

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$456	SK Life Science, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Galyna Pushchinska, MD?

Tedicare shows public-source Medicare data for Galyna Pushchinska, MD (NPI 1710147558), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Galyna Pushchinska, MD have ACO affiliation data?

Galyna Pushchinska, MD is shown with ACO affiliation data for Stony Brook ACO, LLC. (MSSP, ACO ID A4830).

What billing organization is linked to Galyna Pushchinska, MD?

Galyna Pushchinska, MD is linked to NEUROLOGY ASSOCIATES OF STONY BROOK, UNIVERSITY FACULTY PRACTICE CORPO (billing NPI 1699720888) in the available physician profile data.

Does Galyna Pushchinska, MD have Open Payments data?

Galyna Pushchinska, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.